Pages tagged with "Multiple Sclerosis"
- Multiple Sclerosis treated by Vitamin D (includes dose-response)
- 36% of Multiple Sclerosis patients got worse after mild to severe COVID
- Multiple Sclerosis 2.8 X more likely if poor Vitamin D Binding Protein
- Coimbra protocol using high-dose Vitamin D is safe
- Beyond the Coimbra Protocol - 2020
- Gene variants can reduce Vitamin D response by 1.7X (14,000 IU daily, Multiple Sclerosis)
- Multiple Sclerosis Risk factors include virus such as Human Herpesvirus 6A – many studies
- An opportunity - use Vitamin D to treat Multiple Sclerosis (has been used for 14 years)
- Vitamin D is a biomarker for autoimmune, neurological and psychiatric diseases
- White Matter Hyperintensities (brain) 1.8X more likely if 10 ng less vitamin D - meta-analysis
- Two highly-rated guidelines for people with Multiple Sclerosis include Vitamin D
- Epstein-Barr virus increases risk of Multiple Sclerosis by 32X
- COVID death rate was 3X lower in those with Multiple Sclerosis (85 pcnt were taking Vitamin D)
- Mutiple Sclerosis half as likely in children spending 30 to 60 minutes per day in the sun
- Multiple Sclerosis treated by Vitamin D, recommends investigating high dose Coimbra
- Multiple Sclerosis risk increased if both Epstein-Bar Virus and low sun (vitamin D)
- Vitamin D cost-effectively treats Multiple Sclerosis
- Multiple Sclerosis patients had fewer COVID-19 problems (Note: many MSers take Vitamin D)
- Vitamin D and Multiple Sclerosis – book chapter
- Autoimmune and high-dose vitamin D (Dr. Coimbra) - Dr. Mahtani video and transcript